Treatment of t-cell mediated diseases

Details Treatment of t-cell mediated diseases Treatment of t-cell mediated diseases

G - Physics

01

N

G01N 33/567 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/563 (2006.01) G01N 33/566 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2383469

The present invention relates to the discovery that certain adverse inflammatory responses, allergic diseases, undesired immune responses including transplant rejection and autoimmune disease, and other disease states, can be treated or prevented by modulating the binding of the particular chemokines SLC (secondary lymphoid chemokine), and MIP-3.beta. (macrophage inflammatory protein-3b), to immune system T cells and dendritic cells. The present invention is also related to methods for screening for therapeutic compounds useful in the treatment of SLC mediated and MIP-3.beta. mediated disorders, and to the compounds detected by such screens. Appropriate assay methodology is also disclosed.

Affiliated with

Also associated with

Rating

Treatment of t-cell mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of t-cell mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of t-cell mediated diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1911491